Farnoud, A. ; Orak, S. & Schmid, O. Numerical models of respiratory drug deposition and pharmacokinetics: Application to liposomal ciclosporin a (L-CSA). J. Aerosol Med. Pulm. Drug Deliv. 32, A9-A9 (2019)
Orak, S. et al. Towards prediction of the pharmacokinetics of inhaled nanomedicine from physiological cell models: A case study with liposomal ciclosporin A (L-CSA) using the vitrocell cloud system. J. Aerosol Med. Pulm. Drug Deliv. 32, A7-A7 (2019)
Schmid, O. Advanced in vitro and in silico models improve predictions of in vivo/clinical pharmacokinetics of nanocarrier-laden inhaled drugs. J. Aerosol Med. Pulm. Drug Deliv. 32, A4-A4 (2019)
Yang, L. et al. Novel imaging tolls for deciphering pulmonary aerosol deposition with single-cell resolution in non-dissected murine lungs. J. Aerosol Med. Pulm. Drug Deliv. 32, A12-A12 (2019)
Schmid, O. In Memoriam: Dr. Winfried Moller. J. Aerosol Med. Pulm. Drug Deliv. 31, 119-119 (2018)
Schmid, O. et al. Biokinetics of aerosolized liposomal ciclosporin A in human lung cells in vitro using an air-liquid cell interface exposure system. J. Aerosol Med. Pulm. Drug Deliv. 30, 411-424 (2017)
Darquenne, C.* et al. Bridging the gap between science and clinical efficacy: Physiology, imaging, and modeling of aerosols in the lung. J. Aerosol Med. Pulm. Drug Deliv. 29, 107-126 (2016)
Ferron, G.A. & Karg, E.W. Model of the hygroscopic particle deposition in the mouse lungs. J. Aerosol Med. Pulm. Drug Deliv. 28, A38 (2015)
Hofmann, W.* ; Winkler-Heil, R.* ; Möller, W. ; Madl, P.* & Schmidt, O. Modeling particle deposition in the mouse lung and extrapolation to the human lung. J. Aerosol Med. Pulm. Drug Deliv. 28, A43-A43 (2015)
Karg, E.W. ; Ferron, G.A. ; Muelhopt, S.* ; Paur, H.* & Zimmermann, R.* Is the deposited dose in an air-liquid-interface exposure system comparable to the human lungs? J. Aerosol Med. Pulm. Drug Deliv. 28, A34 (2015)
Kreyling, W.G. Biokinetic accumulation of nanoparticles (NP) from lungs to secondary organs and tissues:Contribution of systemically translocated NP across the air-blood barrier versus mucociliary cleared, swallowed and aborbed NP across the gut walls. J. Aerosol Med. Pulm. Drug Deliv. 28, A29 (2015)
Möller, W. et al. In vivo and ex vivo imaging of fluorescent markers in mouse lungs: Assessment of dose and 3D-distribution. J. Aerosol Med. Pulm. Drug Deliv. 28, A38 (2015)
Schittny, J.C.* et al. High resolution phase contrast imaging of sub-micron particles in unstained lung parenchyma. J. Aerosol Med. Pulm. Drug Deliv. 28, A40-A41 (2015)
Lenz, A.-G. et al. Validation of the alice-cloud technology for functional efficacy studie with aerosolized drugs delivered to cells at the air-liquid interface. J. Aerosol Med. Pulm. Drug Deliv. 27, A16 (2014)
Löndahl, J.* et al. Measurement techniques for respiratory tract deposition of airborne nanoparticles: A critical review. J. Aerosol Med. Pulm. Drug Deliv. 27, 229-254 (2014)
Möller, W. et al. Drug delivery to paranasal sinuses using pulsating aerosols. J. Aerosol Med. Pulm. Drug Deliv. 27, 255-263 (2014)
Ferron, G.A. ; Upadhyay, S. ; Zimmermann, R. & Karg, E.W. Model of the deposition of aerosol particles in the respiratory tract of the rat. II. Hygroscopic particle deposition. J. Aerosol Med. Pulm. Drug Deliv. 26, 101-119 (2013)
Lenz, A.-G. et al. Utilizing an efficient air-liquid interface cell exposure system (Alice) for in vitro efficacy testing of aerosolized liquid drugs. J. Aerosol Med. Pulm. Drug Deliv. 26, A16-A17 (2013)
Möller, W. et al. Drug delivery to paranasal sinuses using pulsating aerosols. J. Aerosol Med. Pulm. Drug Deliv. 26, A11-A11 (2013)
Möller, W. et al. Upper airway dead space clearance kinetics and efficiency during nasal high flow. J. Aerosol Med. Pulm. Drug Deliv. 26, A39-A40 (2013)
Schleh, C. et al. Biodistribution of inhaled gold nanoparticles in mice and the influence of surfactant protein D. J. Aerosol Med. Pulm. Drug Deliv. 26, 24-30 (2013)
Möller, W. et al. Fractionated exhaled breath condensate collection shows high hydrogen peroxide release in the airways. J. Aerosol Med. Pulm. Drug Deliv. 23, 129-135 (2010)
Möller, W. et al. Corrections in dose assessment of 99mTc radiolabeled aerosol particles targeted to central human airways using planar gamma camera imaging. J. Aerosol Med. Pulm. Drug Deliv. 22, 45-54 (2009)
Möller, W. ; Meyer, G.* ; Scheuch, G.* ; Kreyling, W.G. & Bennett, W.D.* Left-to-right asymmetry of aerosol deposition after shallow bolus inhalation depends on lung ventilation. J. Aerosol Med. Pulm. Drug Deliv. 22, 333-339 (2009)
Schmid, O. et al. Model for the deposition of aerosol particles in the respiratory tract of the rat. I. Nonhygroscopic particle deposition. J. Aerosol Med. Pulm. Drug Deliv. 21, 291-307 (2008)
Kreyling, W.G. ; Semmler-Behnke, M. & Möller, W. Ultrafine particle-lung interactions: Does size matter? J. Aerosol Med. Pulm. Drug Deliv. 19, 74-83 (2006)
Schulz, S. et al. Cardiovascular effects of fine and ultrafine particles. J. Aerosol Med. Pulm. Drug Deliv. 18, 1-22 (2005)
Kreyling, W.G. ; Semmler, M. & Möller, W. Dosimetry and toxicology of ultrafine particles. J. Aerosol Med. Pulm. Drug Deliv. 17, 140-152 (2004)
Brand, P. et al. Can Aerosol-Derived Airway Morphometry Detect Early, Asymptomatical Lung Emphysema? J. Aerosol Med. Pulm. Drug Deliv. 16, 143-151 (2003)
Schulz, S. ; Eder, G. & Heyder, J. Lung volume is a determinant of aerosol bolus dispersion.  J. Aerosol Med. Pulm. Drug Deliv. 16, 255-262 (2003)
Ibald-Mulli, A. ; Wichmann, H.-E. ; Kreyling, W.G. & Peters, A. Epidemiological Evidence on Health Effects of Ultrafine Particles. J. Aerosol Med. Pulm. Drug Deliv. 15, 189-201 (2002)
Brand, P. ; Beinert, T. ; Frühmann, G. ; Hillebrecht, A. & Heyder, J. Aerosol derived Airway Morphometry at Different Levels of Lung Inflation. J. Aerosol Med. Pulm. Drug Deliv. 6, 165-176 (1993)
Kreyling, W.G. Interspecies Comparison of Lung Clearance of "Insoluble" Particles. J. Aerosol Med. Pulm. Drug Deliv. 3 (Suppl.1), 93-110 (1990)
Stahlhofen, W. ; Rudolf, G. & James, A.C. Intercomparison of Experimental Regional Aerosol Deposition Data. J. Aerosol Med. Pulm. Drug Deliv. 2, 285-308 (1989)
Gebhart, J. ; Heigwer, G. ; Heyder, J. ; Roth, C. & Stahlhofen, W. The Use of Light Scatter Photometry in Aerosol Medicine. J. Aerosol Med. Pulm. Drug Deliv. 1, 89-112 (1988)
Heyder, J. ; Gebhart, J. & Scheuch, G. Influence of Human Lung Morphology on Particle Deposition. J. Aerosol Med. Pulm. Drug Deliv. 1, 81-88 (1988)
Kreyling, W.G. et al. Particle Deposition in the Canine Respiratory Tract. J. Aerosol Med. Pulm. Drug Deliv. (1988)
Kreyling, W.G. et al. Interspecies Comparison of the Lung Clearance of Inhaled Monodisperse Cobalt Oxide: Particle Transport from the Lungs to the GI Tract. J. Aerosol Med. Pulm. Drug Deliv. (1988)
Kreyling, W.G. et al. Interspecies Comparison of the Lung Clearance of Inhaled Monodisperse Cobalt Oxide: Translocation from the Lungs to Blood. J. Aerosol Med. Pulm. Drug Deliv. (1988)
Stahlhofen, W. & Scheuch, G. CHARTING THE UPPER HUMAN AIRWAYS BY MEANS OF AEROSOL BOLUSES. J. Aerosol Med. Pulm. Drug Deliv. (1988)